Table 3.
Parameter/Group | SHAM | OVX | OVX + ESTR | OVX + RA10 | OVX + RA50 | OVX + SA5 | OVX + SA25 |
---|---|---|---|---|---|---|---|
GPx (nmol/min/mg of protein) | 2.31 ± 0.08 | 2.15 ± 0.08 | 2.04 ± 0.07 | 2.26 ± 0.11 | 2.21 ± 0.06 | 2.24 ± 0.08 | 2.28 ± 0.05 |
GR (nmol/min/mg of protein) | 0.367 ± 0.047 | 0.220 ± 0.036 ** | 0.291 ± 0.034 | 0.357 ± 0.027 ^^ | 0.352 ± 0.026 ^^ | 0.323 ± 0.026 ^ | 0.346 ± 0.021 ^ |
G6PD (nmol/min/mg of protein) | 1.99 ± 0.10 | 1.30 ± 0.14* | 1.39 ± 0.17 * | 1.52 ± 0.19 | 1.83 ± 0.16 | 1.47 ± 0.13 | 2.00 ± 0.27 ^ |
GGT (nmol/min/mg of protein) | 0.039 ± 0.005 | 0.024 ± 0.004* | 0.028 ± 0.003 | 0.024 ± 0.004 * | 0.020 ± 0.002 ** | 0.025 ± 0.005 * | 0.031 ± 0.002 |
Rosmarinic acid at doses of 10 mg/kg (OVX + RA10) and 50 mg/kg (OVX + RA50), sinapic acid at doses of 5 mg/kg (OVX + SA5) and 25 mg/kg (OVX + SA25) or estradiol at a dose 0.2 mg/kg (OVX + ESTR) were administered orally to ovariectomized rats, once daily for 28 days. SHAM: sham-operated control rats; OVX: ovariectomized control rats; GPx: glutathione peroxidase; GR: glutathione reductase, G6PD: glucose-6-phosphate dehydrogenase. Results are presented as the mean ± SEM. One-way ANOVA followed by Duncan’s test was used for evaluation of the significance of the results. * p ≤ 0.05, ** p < 0.01: significant differences with regard to the SHAM control rats. ^ p ≤ 0.05, ^^ p < 0.01: significant differences with regard to the OVX control rats. No statistically significant differences in results for GPx were demonstrated by ANOVA.